Helicobacter pylori: host genetics and disease outcomes

References

• Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet1, 1311–1315 (1984).
   PubMed Web of Science ®Google Scholar
• IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. IARC, Lyon, France, 177–240 (1994).
   Google Scholar
• Malaty HM, El-Kasabany A, Graham DY et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet359, 931–935 (2002).
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA282, 2240–2245 (1999).
   PubMed Web of Science ®Google Scholar
• Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol. Rev.13, 42–59 (1991).
   PubMed Web of Science ®Google Scholar
• Freeman HJ. Disappearance of Helicobacter without antibiotics in 12 patients with gastritis. Can. J. Gastroenterol.11, 167–172 (1997).
   PubMed Web of Science ®Google Scholar
• Tham TC, Sloan JM, Collins JS. Long-term semi-quantitative follow-up of Helicobacter pylori associated gastritis. Ir. J. Med. Sci.166, 132–134 (1997).
   PubMed Web of Science ®Google Scholar
• Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology134, 306–323 (2008).
   PubMed Web of Science ®Google Scholar
• Graham DY, Opekun AR, Osato MS et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut53, 1235–1243 (2004).
   PubMed Web of Science ®Google Scholar
• Danon SJ, O’Rourke JL, Moss ND et al. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology108, 1386–1395 (1995).
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Lundell L, Klinkenberg-Knol EC et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N. Engl. J. Med.33, 1018–1022 (1996).
   Google Scholar
• Israel DA, Peek RM. Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol. Ther.15, 1271–1290 (2001).
   PubMed Web of Science ®Google Scholar
• Robert A, Olafsson AS, Lancaster C et al. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci.48, 123–134 (1991).
   PubMed Web of Science ®Google Scholar
• Wolfe MM, Nompleggi DJ. Cytokine inhibition of gastric acid secretion – a little goes a long way. Gastroenterology102, 2177–2178 (1992).
   PubMedGoogle Scholar
• Beales IL, Calam J. Interleukin 1 β and tumour necrosis factor α inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 42, 227–234 (1998).
   Google Scholar
• El-Omar EM, Oien K, El Nujumi A et al.Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology113, 15–24 (1997).
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Penman ID, Ardill JE et al.Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology109, 681–691 (1995).
   PubMed Web of Science ®Google Scholar
• McColl KE, El-Omar E, Gillen D. Helicobacter pylori gastritis and gastric physiology. Gastroenterol. Clin. North Am.29, 687–703 (2000).
   PubMed Web of Science ®Google Scholar
• Danon SJ, O’Rourke JL, Moss ND et al. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology108, 1386–1395 (1995).
   PubMed Web of Science ®Google Scholar
• Lundell L, Havu N, Miettinen P et al. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Aliment Pharmacol. Ther.23, 639–647 (2006).
   PubMed Web of Science ®Google Scholar
• Kuipers EJ. Proton pump inhibitors and gastric neoplasia. Gut55, 1217–1221 (2006).
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG. Omeprazole and accelerated onset of atrophic gastritis. Gastroenterology118, 239–242 (2000).
   PubMedGoogle Scholar
• Malaty HM, Engstrand L, Pedersen NL et al.Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann. Intern. Med.120, 982–986 (1994).
   PubMed Web of Science ®Google Scholar
• Tseng FC, Brown EE, Maiese EM et al. Polymorphisms in cytokine genes and risk of Helicobacter pylori infection among Jamaican children. Helicobacter11, 425–430 (2006).
   PubMed Web of Science ®Google Scholar
• Liou JM, Lin JT, Wang HP et al.IL-1B-511 C-->T polymorphism is associated with increased host susceptibility to Helicobacter pylori infection in Chinese. Helicobacter12, 142–149 (2007).
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J. Clin.55, 74–108 (2005).
   PubMed Web of Science ®Google Scholar
• Graham DY, Yamaoka Y. Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter5(Suppl. 1), S3–S9 (2000).
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Biologic basis for interleukin-1 in disease. Blood87, 2095–2147 (1996).
   PubMed Web of Science ®Google Scholar
• El-Omar EM. The importance of interleukin 1β in Helicobacter pylori associated disease. Gut48, 743–747 (2001).
   PubMed Web of Science ®Google Scholar
• Bidwell J, Keen L, Gallagher G et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun.2, 61–70 (2001).
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature404, 398–402 (2000).
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Rabkin CS, Gammon MD et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology124, 1193–1201 (2003).
   PubMed Web of Science ®Google Scholar
• Machado JC, Pharoah P, Sousa S et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology121, 823–829 (2001).
   PubMed Web of Science ®Google Scholar
• Figueiredo C, Machado JC, Pharoah P et al.Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl Cancer Inst.94, 1680–1687 (2002).
   PubMed Web of Science ®Google Scholar
• Machado JC, Figueiredo C, Canedo P et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology125, 364–371 (2003).
   PubMed Web of Science ®Google Scholar
• Rad R, Prinz C, Neu B et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J. Infect. Dis.188, 272–281 (2003).
   PubMed Web of Science ®Google Scholar
• Palli D, Saieva C, Luzzi I et al. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am. J. Gastroenterol.100, 1941–1948 (2005).
   PubMed Web of Science ®Google Scholar
• Furuta T, El-Omar EM, Xiao F et al. Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology123, 92–105 (2002).
   PubMed Web of Science ®Google Scholar
• Zeng ZR, Hu PJ, Hu S et al. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut52, 1684–1689 (2003).
   PubMed Web of Science ®Google Scholar
• Lee KA, Ki CS, Kim HJ et al. Novel interleukin 1β polymorphism increased the risk of gastric cancer in a Korean population. J. Gastroenterol.39, 429–433 (2004).
   PubMed Web of Science ®Google Scholar
• Chang YW, Jang JY, Kim NH et al. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1β cytokine in Korean patients with gastric cancer. Int. J. Cancer114, 465–471 (2005).
   PubMed Web of Science ®Google Scholar
• Yang J, Hu Z, Xu Y et al. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett.215, 191–198 (2004).
   PubMed Web of Science ®Google Scholar
• Chen HM, Wilkins LM, Aziz N et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum. Mol. Genet.15, 519–529 (2006).
   PubMed Web of Science ®Google Scholar
• Lee KA, Park JH, Sohn TS et al. Interaction of polymorphisms in the Interleukin 1B-31 and general transcription factor 2A1 genes on the susceptibility to gastric cancer. Cytokine38, 96–100 (2007).
   PubMed Web of Science ®Google Scholar
• Shen J, Arnett DK, Peacock JM et al. Interleukin1β genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. J. Nutr.137, 1846–1851 (2007).
   PubMed Web of Science ®Google Scholar
• Tu S, Cui G, Takaishi S et al. Overexpression of human interleukin-1 β in transgenic mice results in spontaneous gastric inflammation and carcinogenesis. Gastroenterology128(4 Suppl. 2), A62 (2005).
   Google Scholar
• Lu W, Pan K, Zhang L et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor α and risk of gastric cancer in a Chinese population. Carcinogenesis26, 631–636 (2005).
   PubMed Web of Science ®Google Scholar
• Taguchi A, Ohmiya N, Shirai K et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol. Biomarkers Prev.14, 2487–2493 (2005).
   PubMed Web of Science ®Google Scholar
• Lee WP, Tai DI, Lan KH et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin. Cancer Res.11, 6431–6441 (2005).
   PubMed Web of Science ®Google Scholar
• Ohyauchi M, Imatani A, Yonechi M et al. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut54, 330–335 (2005).
   PubMed Web of Science ®Google Scholar
• Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol. Ther.13(Suppl. 1), 3–11 (1999).
   PubMedGoogle Scholar
• Segal ED, Lange C, Covacci A et al. Induction of host signal transduction pathways by Helicobacter pylori. Proc. Natl Acad. Sci. USA94, 7595–7599 (1997).
   PubMed Web of Science ®Google Scholar
• Su B, Ceponis PJ, Lebel S et al.Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect. Immun.71, 3496–3502 (2003).
   PubMed Web of Science ®Google Scholar
• Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol.560, 11–18 (2005).
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. Toll-like receptors in innate immunity. Int. Immunol.17, 1–14 (2005).
   PubMed Web of Science ®Google Scholar
• Arbour NC, Lorenz E, Schutte BC et al.TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet.25, 187–191 (2000).
   PubMed Web of Science ®Google Scholar
• Franchimont D, Vermeire S, El Housni H et al. Deficient host–bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis. Gut53, 987–992 (2004).
   PubMed Web of Science ®Google Scholar
• Lorenz E, Mira JP, Frees KL et al. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch. Intern. Med.162, 1028–1032 (2002).
   PubMed Web of Science ®Google Scholar
• Kiechl S, Lorenz E, Reindl M et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med.347, 185–192 (2002).
   PubMed Web of Science ®Google Scholar
• Higgins SC, Lavelle EC, McCann C et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol.171, 3119–3127 (2003).
   PubMed Web of Science ®Google Scholar
• Hold GL, Rabkin CS, Chow WH et al. A functional polymorphism of Toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology132, 905–912 (2007).
   PubMed Web of Science ®Google Scholar
• Sanduleanu S, Jonkers D, De Bruine A et al. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis. Aliment. Pharmacol. Ther.15, 1163–1175 (2001).
   PubMed Web of Science ®Google Scholar
• Zavros Y, Rieder G, Ferguson A et al. Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology122, 119–133 (2002).
   PubMed Web of Science ®Google Scholar
• Baccarelli A, Hou L, Chen J et al. Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int. J. Cancer119, 1970–1975 (2006).
   PubMed Web of Science ®Google Scholar
• Zanke BW, Greenwood CM, Rangrej J et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat. Genet.39, 989–994 (2007).
   PubMed Web of Science ®Google Scholar
• Haiman CA, Le Marchand L, Yamamato J et al. A common genetic risk factor for colorectal and prostate cancer. Nat. Genet.39, 954–956 (2007).
   PubMed Web of Science ®Google Scholar
• Tomlinson I, Webb E, Carvajal-Carmona L et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet.39, 984–988 (2007).
   PubMed Web of Science ®Google Scholar